Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Mathew Cherian, Alexa Magner et al.|Frontiers in Oncology|2020Cited by 127
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, Craig Vargo, M. Alexandra Schickli et al.|Clinical Breast Cancer|2019Cited by 47
Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivorsAllison Quick, Maryam B. Lustberg, Raquel E. Reinbolt et al.|Supportive Care in Cancer|2019Cited by 43
Worry and rumination in breast cancer patients: perseveration worsens self-rated healthMegan E. Renna, Janice K. Kiecolt‐Glaser, M. Rosie Shrout et al.|Journal of Behavioral Medicine|2020Cited by 41
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Robert Wesolowski, Mohamed Badawi et al.|Investigational New Drugs|2020Cited by 37